NEAT1 and renal cell carcinoma: Further investigation revealed that NEAT1 enhanced RCC cell proliferation, migration, invasion, and EMT, and inhibited cell cycle progression by sponging miR-34a, thus increasing the expression level of c-Met, a potential therapeutic target in cancers 140.